Q2 2023 · 13F-HR
Column Group LLCholdings as filed
Filed 2023-07-24 · accession 0000950123-23-006249
$257.7M
Reported value
7
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 76155X100 | RVMD | Revolution Medicines Inc | $68.9M | 26.8% | 2,577,220 | Common | SOLE |
| 87990A106 | TNYA | Tenaya Therapeutics, Inc. | $55.2M | 21.4% | 9,400,290 | Common | SOLE |
| 75382E109 | — | RAPT Therapeutics Inc | $50.1M | 19.5% | 2,680,621 | Common | SOLE |
| 62921N105 | NGMUSD | NGM Biopharmaceuticals Inc | $47.0M | 18.2% | 18,136,735 | Common | SOLE |
| 68622P109 | ORIC | ORIC Pharmaceuticals Inc. | $27.7M | 10.7% | 3,568,181 | Common | SOLE |
| 86889P109 | — | Surrozen, Inc. | $5.2M | 2.01% | 9,414,795 | Common | SOLE |
| 28202V108 | — | eFFECTOR Therapeutics Inc | $3.6M | 1.39% | 4,309,329 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.